Navigation Links
HMS Holdings Corp. Announces First Quarter 2009 Financial Results

Revenue Up 28%, EPS Up 77% Over Prior Year

NEW YORK, May 1 /PRNewswire-FirstCall/ -- HMS (Nasdaq: HMSY) today announced financial results for its first quarter ended March 31, 2009.

For the first quarter of 2009, revenue increased 28.2% to $49.9 million, compared with $38.9 million for the same period a year ago. Net income for the quarter was $5.7 million or $0.21 per fully diluted share compared to net income of $3.2 million or $0.12 per fully diluted share for the same period a year ago. Adjusted EBITDA for the quarter increased 54.9% to $14.5 million versus $9.3 million for the first quarter of 2008.

"HMS's first quarter represents a strong start to what we expect will be an excellent 2009," said Bill Lucia, CEO. "We are seeing revenue growth and new business in each of the markets we serve."

HMS will be hosting its first quarter 2009 conference call and webcast with the investment community on Friday, May 1, 2009 at 9:00 am Eastern Time. The conference call number is US/Canada: (866) 394-8630 Int'l/Local Dial-In: (706) 758-0082 Conference ID: 90944724. A slide presentation will accompany the conference call and may be accessed through our website at

A conference call replay will be available beginning May 1, 2009 10:00 AM ET through May 7, 2009 11:59 PM ET. To listen to the replay of the call, dial: US/Canada: (800) 642-1687 Int'l/Local Dial-In: (706) 645-9291 Conference ID: 90944724 or visit our website at

The HMS Holdings Corp. Form 10-Q for the quarter ended March 31, 2009 will be filed and available on our website on or about May 12, 2009, and will contain additional information about our results of operations for the fiscal year-to-date. This press release and the interim financial statements herein will be available at for at least a 12-month period. Shareholders and interested investors are welcome to contact Investor Relations at 212-857-5986.

About HMS (Nasdaq: HMSY)

HMS is the leader in coordination of benefits and program integrity services for government healthcare programs. The company's clients include health and human services programs in more than 40 states, over 90 Medicaid managed care plans, the Centers for Medicare and Medicaid Services (CMS), and Veterans Administration facilities. HMS helps ensure that healthcare claims are paid correctly and by the responsible party. As a result of the company's services, government healthcare programs recover over $1 billion annually, and avoid billions of dollars more in erroneous payments.

This press release includes presentations of earnings before interest, taxes, depreciation and amortization (EBITDA) and adjusted EBITDA. Adjusted EBITDA represents EBITDA adjusted for share-based compensation expense. EBITDA is a measure commonly used by the capital markets to value enterprises. Interest, taxes, depreciation and amortization can vary significantly between companies due in part to differences in accounting policies, tax strategies, levels of indebtedness and interest rates. Excluding these items provides insight into the underlying results of operations and facilitates comparisons between HMSY and other companies. EBITDA is also a useful measure of the Company's ability to service debt and is one of the measures used for determining debt covenant compliance. In addition, because of the varying methodologies for determining share-based compensation expense, and the subjective assumptions involved in those determinations, we believe excluding share-based compensation expense from EBITDA enhances the ability of management and investors to compare our core operating results over multiple periods with those of other companies. Management believes EBITDA and adjusted EBITDA information is useful to investors for these reasons. Both EBITDA and adjusted EBITDA are non-GAAP financial measures and should not be viewed as an alternative to GAAP measures of performance. Management believes the most directly comparable GAAP financial measure is net income and has provided a reconciliation of EBITDA and adjusted EBITDA to net income in this press release.

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Such forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause the actual results, performance, or achievements of HMSY, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. The important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i) the information being of a preliminary nature and therefore subject to further adjustment; (ii) the uncertainties of litigation; (iii) HMSY's dependence on significant customers; (iv) changing conditions in the healthcare industry which could simplify the reimbursement process and adversely affect HMSY's business; (v) government regulatory and political pressures which could reduce the rate of growth of healthcare expenditures and/or discourage the assertion of claims for reimbursement against and delay the ultimate receipt of payment from third party payors; (vi) competitive actions by other companies, including the development by competitors of new or superior services or products or the entry into the market of new competitors; (vii) all the risks inherent in the development, introduction, and implementation of new products and services; and (viii) other risk factors described from time to time in HMSY's filings with the Securities and Exchange Commission, including HMSY's Annual Report on Form 10-K for the year ended December 31, 2008. HMSY assumes no responsibility to update the forward-looking statements contained in this release as a result of new information, future events or otherwise. When/if used in this release, the words "focus", "believe", "confident", "anticipate", "expected", "strong", "potential", and similar expressions are intended to identify forward-looking statements, and the above described risks inherent therein.

                          HMS HOLDINGS CORP. AND SUBSIDIARIES
                           Consolidated Statements of Income
                        (In Thousands, Except Per Share Amounts)

                                                Three months ended March 31,

                                                    2009               2008
                                                  -------            -------
    Revenue                                       $49,941            $38,943

    Cost of services:
             Compensation                          17,531             13,724
             Data processing                        3,146              2,717
             Occupancy                              2,734              2,361
             Direct project costs                   6,325              6,044
             Other operating costs                  2,998              2,145
             Amortization of acquisition
               related software and intangibles     1,216              1,163
                                                  -------            -------
                   Total cost of services          33,950             28,154

    Selling, general & administrative expenses      6,131              5,100
                                                  -------            -------
                   Total operating expenses        40,081             33,254
                                                  -------            -------
             Operating income                       9,860              5,689

    Interest expense                                 (287)             (415)
    Interest income                                    97                197
                                                  -------            -------
             Income before income taxes             9,670              5,471
    Income taxes                                    3,965              2,298
                                                  -------            -------
    Net Income                                     $5,705             $3,173
                                                  =======            =======
    Net income per common share:
             Basic                                  $0.22              $0.13
             Diluted                                $0.21              $0.12

    Weighted average shares:
             Basic                                 25,614             24,826
                                                  =======            =======
             Diluted                               27,205             26,834
                                                  =======            =======

                           Consolidated Balance Sheets
                (In Thousands, Except Share and Per Share Amounts)

                                                    March 31,     December 31,
      Assets                                          2009            2008
    Current Assets:                                 --------        --------
          Cash and cash equivalents                  $53,134         $49,216
          Accounts receivable, net of
            allowance of $664 at March 31, 2009
            and December 31, 2008, respectively       46,547          45,155
          Prepaid expenses and other current
            assets, including deferred tax assets
            of $1,495 and $1,697 at March 31, 2009
            and December 31, 2008, respectively        5,319           5,541
                                                    --------        --------
            Total current assets                     105,000          99,912

    Property and equipment, net                       17,502          17,757
    Goodwill, net                                     82,342          82,342
    Deferred income taxes, net                         1,971           2,040
    Intangible assets, net                            18,759          19,823
    Other assets                                         593             639
                                                    --------        --------
            Total assets                            $226,167        $222,513
                                                    ========        ========
      Liabilities and Shareholders' Equity
    Current Liabilities:
            Accounts payable, accrued expenses
              and other liabilities                  $15,718         $22,859
            Current portion of long term-debt          6,300           6,300
                                                    --------        --------
              Total current liabilities               22,018          29,159
                                                    --------        --------
    Long-term liabilities:
            Long-term debt                             9,450          11,025
            Other liabilities                          3,830           3,967
                                                    --------        --------
              Total long-term liabilities             13,280          14,992
                                                    --------        --------
         Total liabilities                            35,298          44,151
                                                    --------        --------

    Shareholders' Equity:
      Preferred Stock - $. 01 par value;
        5,000,000 shares authorized; none issued          -               -
      Common Stock - $.01 par value; 45,000,000
        shares authorized;
          27,510,912 shares issued and 25,848,066
            shares outstanding at March 31, 2009;
          27,174,875 shares issued and 25,512,029
            shares outstanding at December 31, 2008;     275             272
    Capital in excess of par value                   152,875         146,145
    Retained earnings                                 47,267          41,562
    Treasury stock, at cost; 1,662,846 shares
      at March 31, 2009 and December 31, 2008         (9,397)         (9,397)
    Accumulated other comprehensive loss                (151)           (220)
                                                    --------         --------
      Total shareholders' equity                     190,869          178,362
                                                    --------         --------
         Total liabilities and
           shareholders' equity                     $226,167         $222,513
                                                    --------         --------

                       Consolidated Statements of Cash Flows
                 For the Three months ended March 31, 2009 and 2008
                                  (in Thousands)

                                                  Three months ended March 31,
                                                      2009             2008
                                                    -------          -------
    Operating activities:
      Net income                                     $5,705           $3,173
        Adjustments to reconcile net income
          to net cash provided by
          operating activities:
            Loss on disposal of fixed assets              1                -
            Depreciation and amortization             3,359            2,911
            Share-based compensation expense          1,308              798
            Decrease in deferred tax asset              271               47
            Changes in assets and liabilities:
              Increase in accounts receivable        (1,392)          (2,252)
              Decrease in prepaid expenses and
                other current assets                    751              677
              Decrease (increase) in other assets         1               (4)
              Decrease in accounts payable, accrued
                expenses and other liabilities*      (5,845)          (8,855)
                                                    -------           -------
                Net cash provided by (used in)
                  operating activities                4,159           (3,505)
                                                    -------           -------
    Investing activities:
      Purchases of property and equipment            (3,005)          (2,044)
      Investment in capitalized software               (355)            (180)
                                                    -------           -------
                Net cash used in investing
                 activities                          (3,360)          (2,224)
                                                    -------           -------
    Financing activities:
      Proceeds from exercise of stock options         1,586              754
      Repayment of long-term debt                    (1,575)          (1,575)
      Tax benefit of disqualifying dispositions*      3,108            1,979
                                                    -------           -------
                Net cash provided by financing
                 activities                           3,119            1,158
                                                    -------           -------
        Net increase (decrease) in cash and
          cash equivalents                            3,918           (4,571)

    Cash and cash equivalents at beginning
      of period                                      49,216           21,275
                                                    -------           -------
    Cash and cash equivalents at end of period      $53,134           $16,704
                                                    =======           =======
    Supplemental disclosure of cash flow
        Cash paid for income taxes                      $75               $38
                                                    =======           =======
        Cash paid for interest                         $232              $383
                                                    =======           =======
    Supplemental disclosure of noncash
      investing activities:
        Accrued property and equipment purchases       $534               $-
                                                    =======           =======

    * March 2008 presentation was modified to conform with a revised 2009 reporting format.

             Reconciliation of net income to EBITDA and adjusted EBITDA
                  (In Thousands, Except Share and Per Share Amounts)

    As summarized in the following table, earnings before interest, taxes, depreciation and amortization, and share based compensation expense (adjusted EBITDA) was $14.5 million for the first quarter of 2009, an increase of 54.9% over the same period a year ago.

    Reconciliation of net income to
      EBITDA and adjusted EBITDA                   Three Months Ended
                                                        March 31,
                                                    2009         2008
                                                    ----         ----
    Net Income                                     $5,705       $3,173

    Net interest expense                              190          218
    Income taxes                                    3,965        2,298
    Depreciation and amortization, net
      of deferred financing costs, included
      in net interest expense (income)              3,314        2,860
                                                  -------      -------
      Earnings before interest, taxes,
        depreciation and amortization (EBITDA)     13,174        8,549
    Share-based compensation expense                1,308          798
                                                  -------      -------
        Adjusted EBITDA                           $14,482       $9,347
                                                  =======      =======

SOURCE HMS Holdings Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
4. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
5. Siemens Announces Early Termination of Hart-Scott-Rodino Waiting Period For Acquisition of Dade Behring Holdings, Inc.; U.S. Antitrust Clearance Achieved
6. Platinum Underwriters Holdings, Ltd. to Report Third Quarter 2007 Results on October 23, 2007
7. Air Methods Completes Acquisition of FSS Airholdings, Inc., Parent Company of CJ Systems Aviation Group, Inc.
8. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
9. NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call
10. HMS Holdings Corp. Hosts Third Quarter 2007 Financial Teleconference and Presentation
11. China Shenghuo Pharmaceutical Holdings, Inc. Opens Showcase 12Ways(R) Chinese Herbal Beauty Salon in October
Post Your Comments:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... locations throughout Arkansas that offers insurance and financial preparation services, is providing an ... Rock City Rescue organization. , Rock City Rescue is a locally recognized nonprofit ...
(Date:10/13/2017)... ... , ... While it’s often important to take certain medications during the night, ... has identified a solution. , She developed a prototype for MOTION LIGHT-UP PILL BOX ... eliminates the need to turn on a light when taking medication during the night, ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... ... established the certification process to promote standards of excellence for the field of ... scheduled for March 22 – 25, 2018 in Orlando, Florida at the Omni ...
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... Shelton, CT (PRWEB) , ... October 13, 2017 , ... ... and long-term care services, staged a mock evacuation of the facility as part of ... Department, Shelton Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Halo Labs announces the European launch of their new ... at MIBio 2017 in Cambridge, U.K on ... in biopharmaceutical samples with unprecedented speed and sensitivity while using far ... Membrane Imaging. ... particle analysis system ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/22/2017)... , Sept. 22, 2017 AVACEN Medical ... device is now successfully helping those with the widespread ... Fibromyalgia diagnosed Amanda in Essex, England ... and washing my hair, experiencing no sleep at all, ... painful spasm… I cannot recommend [the AVACEN 100] enough, ...
Breaking Medicine Technology: